UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
|
|||
FORM 8-K
|
|||
CURRENT REPORT
|
|||
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
|
|||
Date of Report (Date of earliest event reported) September 8, 2014 |
RETROPHIN, INC.
|
|||
(Exact name of registrant as specified in its charter)
|
Delaware
|
001-36257
|
27-4842691
|
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
777 Third Avenue, 22nd Floor, New York, NY
|
10017
|
||
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code (646) 837-5863
|
(Former name or former address, if changed since last report.)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|||
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
||
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
||
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
||
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))
|
Week 0
|
Week 1
|
Week 2
|
Week 3
|
Week 4
|
Week 5
|
Week 7
|
Week 11
|
Week 15
|
||||||||||||||||||||||||||||
SUBJECT 1
|
||||||||||||||||||||||||||||||||||||
UPDRS1 (A+B+C)
|
74/118 | 56/118 | 56/118 | 63/118 | 58/118 | 56/118 | 48/118 | 50/118 | 47/118 | |||||||||||||||||||||||||||
Subscale A
|
8/10 | 3/10 | 3/10 | 3/10 | 4/10 | 3/10 | 2/10 | 3/10 | 2/10 | |||||||||||||||||||||||||||
Subscale B
|
36/52 | 26/52 | 26/52 | 27/52 | 26/52 | 26/52 | 23/52 | 22/52 | 21/52 | |||||||||||||||||||||||||||
Subscale C
|
30/56 | 27/56 | 27/56 | 33/56 | 28/56 | 27/56 | 23/56 | 25/56 | 24/56 | |||||||||||||||||||||||||||
BADS2
|
14/24 | 15/24 | 14/24 | 16/24 | 13/24 | 14/24 | 13/24 | 14/24 | 13/24 | |||||||||||||||||||||||||||
EQ-5D-3L
|
12/15 | 12/15 | 10/15 | 10/15 | 9/15 | 9/15 | 8/15 | 10/15 | 10/15 | |||||||||||||||||||||||||||
25 foot walk test
|
||||||||||||||||||||||||||||||||||||
# of steps
|
25.5 | 19.5 | 17.0 | 16.0 | 16.5 | 15.0 | 14.0 | 14.5 | 15.0 | |||||||||||||||||||||||||||
Time in seconds
|
10.5 | 11.3 | 8.6 | 11.1 | 8.9 | 8.2 | 7.6 | 7.8 | 6.4 |
SUBJECT 2 | Week 0 | Week 13 | ||
UPDRS (A+B+C) | 53/118 | 36/118 | ||
Subscale A | 4/10 | 4/10 | ||
Subscale B | 23/52 | 17/52 | ||
Subscale C | 26/56 | 15/56 | ||
BADS | 14/24 | 13/24 |
Week 0
|
Week 1
|
Week 2
|
Week 3
|
Week 4
|
Week 5
|
Week 7
|
Week 11
|
Week 15
|
||||||||||||||||||||||||||||
SUBJECT 1
|
||||||||||||||||||||||||||||||||||||
ALT (IU/L)
|
34 | 31 | 85 | 65 | 38 | 35 | 27 | 29 | 27 | |||||||||||||||||||||||||||
AST (IU/L)
|
26 | 23 | 55 | 32 | 29 | 30 | 26 | 28 | 27 | |||||||||||||||||||||||||||
Lactate (mmol/L)
|
2.44 | 1.42 | 1.46 | 1.29 | 1.69 | 1.07 | 1.28 | 1.39 | 1.7 |
RETROPHIN, INC.
|
|||
Date: September 8, 2014
|
By:
|
/s/ Marc Panoff | |
Name: Marc Panoff
|
|||
Title: Chief Financial Officer | |||